{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:38:02Z","timestamp":1792615082468,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obstetrics and Gynecology Clinics of North America"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ogc.2023.02.009","type":"journal-article","created":{"date-parts":[[2023,4,2]],"date-time":"2023-04-02T08:46:23Z","timestamp":1680425183000},"page":"375-387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Group B Streptococcus in Pregnancy"],"prefix":"10.1016","volume":"50","author":[{"given":"Jenny Y.","family":"Mei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil S.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 4","key":"10.1016\/j.ogc.2023.02.009_bib1","doi-asserted-by":"crossref","first-page":"D20","DOI":"10.1016\/j.vaccine.2012.11.056","article-title":"Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine","volume":"31","author":"Schrag","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.ogc.2023.02.009_bib2","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/infdis\/148.5.795","article-title":"Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. I. Epidemiologic rationale","volume":"148","author":"Boyer","year":"1983","journal-title":"J\u00a0Infect Dis"},{"issue":"3","key":"10.1016\/j.ogc.2023.02.009_bib3","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/jamapediatrics.2018.4826","article-title":"Epidemiology of Invasive Early-Onset and Late-Onset Group B Streptococcal Disease in the United States, 2006 to 2015: Multistate Laboratory and Population-Based Surveillance","volume":"173","author":"Nanduri","year":"2019","journal-title":"JAMA Pediatr"},{"issue":"2","key":"10.1016\/j.ogc.2023.02.009_bib4","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1097\/AOG.0000000000003668","article-title":"Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion, Number 797","volume":"135","author":"Prevention of Group","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2023.02.009_bib5","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/infdis\/137.5.524","article-title":"Epidemiology of group B Streptococcus: longitudinal observations during pregnancy","volume":"137","author":"Anthony","year":"1978","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ogc.2023.02.009_bib6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0022-3476(79)80530-2","article-title":"Epidemiology of the group B streptococcus: maternal and nosocomial sources for infant acquisitions","volume":"95","author":"Anthony","year":"1979","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.ogc.2023.02.009_bib7","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1001\/jama.299.17.2056","article-title":"Epidemiology of invasive group B streptococcal disease in the United States, 1999\u20132005. Active Bacterial Core surveillance\/Emerging Infections Program Network","volume":"299","author":"Phares","year":"2008","journal-title":"JAMA"},{"issue":"suppl 4","key":"10.1016\/j.ogc.2023.02.009_bib8","doi-asserted-by":"crossref","first-page":"D7","DOI":"10.1016\/j.vaccine.2013.01.009","article-title":"An overview of global GBS epidemiology","volume":"31","author":"Le Doare","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.ogc.2023.02.009_bib9","doi-asserted-by":"crossref","first-page":"e20162013","DOI":"10.1542\/peds.2016-2013","article-title":"Epidemiology of invasive early-onset neonatal sepsis, 2005 to 2014","volume":"138","author":"Schrag","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.ogc.2023.02.009_bib10","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1542\/peds.2012-1231","article-title":"Group B streptococcus late-onset disease: 2003\u20132010. GBS Prevention Working Group, Emilia-Romagna","volume":"131","author":"Berardi","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.ogc.2023.02.009_bib11","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1093\/cid\/cix655","article-title":"Risk of early-onset neonatal group B streptococcal disease with maternal colonization worldwide: systematic review and meta-analyses","volume":"65","author":"Russell","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ogc.2023.02.009_bib12","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/INF.0000000000001414","article-title":"Neonatal group B streptococcus infections: prevention strategies, clinical and microbiologic characteristics in 7 years of surveillance. Italian Neonatal GBS Infections Working Group","volume":"36","author":"Creti","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ogc.2023.02.009_bib13","first-page":"498","article-title":"Group B streptococcal colonization and serotype-specific immunity in pregnant women at delivery","volume":"96","author":"Campbell","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2023.02.009_bib14","first-page":"604","article-title":"The epidemiology of group B streptococcal colonization in pregnancy. Vaginal Infections and Prematurity Study Group","volume":"77","author":"Regan","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2023.02.009_bib15","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1093\/cid\/cix664","article-title":"Estimates of the burden of group B streptococcal disease worldwide for pregnant women, stillbirths, and children","volume":"65","author":"Seale","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ogc.2023.02.009_bib16","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1080\/00016340600780508","article-title":"Morbidity related to maternal group B streptococcal infections","volume":"85","author":"Muller","year":"2006","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ogc.2023.02.009_bib17","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1093\/cid\/cix661","article-title":"Preterm birth associated with group B streptococcus maternal colonization worldwide: systematic review and meta-analyses","volume":"65","author":"Bianchi-Jassir","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ogc.2023.02.009_bib18","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/00006454-199407000-00008","article-title":"Multistate case\u2013control study of maternal risk factors for neonatal group B streptococcal disease. The Active Surveillance Study Group","volume":"13","author":"Schuchat","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ogc.2023.02.009_bib19","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.3109\/14767058.2012.671872","article-title":"Bacteriuria with group-B streptococcus: is it a risk factor for adverse pregnancy outcomes?","volume":"25","author":"Kessous","year":"2012","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ogc.2023.02.009_bib20","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0029-7844(97)00247-0","article-title":"Persistence of penicillin G benzathine in pregnant group B streptococcus carriers","volume":"90","author":"Weeks","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2023.02.009_bib21","first-page":"CD003520","article-title":"Vaginal chlorhexidine during labour to prevent early-onset neonatal group B streptococcal infection","volume":"12","author":"Ohlsson","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ogc.2023.02.009_bib22","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/infdis\/148.5.802","article-title":"Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures","volume":"148","author":"Boyer","year":"1983","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ogc.2023.02.009_bib23","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0029-7844(96)00320-1","article-title":"The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery","volume":"88","author":"Yancey","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2023.02.009_bib24","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0029-7844(94)00412-7","article-title":"Enhanced antenatal detection of group B streptococcus colonization","volume":"85","author":"Philipson","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2023.02.009_bib25","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/0002-9378(95)91380-7","article-title":"The accuracy and patient preference for self-collected group B streptococcus cultures","volume":"173","author":"Mercer","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2023.02.009_bib26","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.cmi.2018.01.008","article-title":"Evaluation of hibergene loop-mediated isothermal amplification assay for detection of group B streptococcus in recto-vaginal swabs: a prospective diagnostic accuracy study","volume":"24","author":"Curry","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ogc.2023.02.009_bib27","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1128\/JCM.00594-10","article-title":"Real-time PCR assay provides reliable assessment of intrapartum carriage of group B Streptococcus","volume":"48","author":"Alfa","year":"2010","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.ogc.2023.02.009_bib28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/00016340701802888","article-title":"Group B streptococcal carriage in Sweden: a national study on risk factors for mother and infant colonisation. Swedish Working Group For The Prevention of Perinatal Group B Streptococcal Infections","volume":"87","author":"Hakansson","year":"2008","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ogc.2023.02.009_bib29","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1097\/AOG.0000000000002833","article-title":"Use of prophylactic antibiotics in labor and delivery. ACOG Practice Bulletin No. 199. American College of Obstetricians and Gynecologists","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2023.02.009_bib30","first-page":"510","article-title":"Efficiency of screening for the recurrence of antenatal group B streptococcus colonization in a subsequent pregnancy: a systematic review and meta-analysis with independent patient data","volume":"33","author":"Turrentine","year":"2016","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ogc.2023.02.009_bib31","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1099\/jmm.0.000465","article-title":"Group B streptococcal bacteriuria during pregnancy as a risk factor for maternal intrapartum colonization: a prospective cohort study","volume":"66","author":"Perez-Moreno","year":"2017","journal-title":"J\u00a0Med Microbiol"},{"key":"10.1016\/j.ogc.2023.02.009_bib32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijgo.2007.10.012","article-title":"Prenatal antibiotic treatment does not decrease group B streptococcus colonization at delivery","volume":"101","author":"Baecher","year":"2008","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"10.1016\/j.ogc.2023.02.009_bib33","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/jamapediatrics.2020.4719","article-title":"Antibiotic Susceptibility of Escherichia coli Among Infants Admitted to Neonatal Intensive Care Units Across the US From 2009 to 2017","volume":"175","author":"Flannery","year":"2021","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.ogc.2023.02.009_bib34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/AOG.0b013e31817d0246","article-title":"Duration of intrapartum prophylaxis and concentration of penicillin G in fetal serum at delivery","volume":"112","author":"Barber","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2023.02.009_bib35","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/jama.1979.03290380021019","article-title":"Ampicillin prevents intrapartum transmission of group B streptococcus","volume":"241","author":"Yow","year":"1979","journal-title":"JAMA"},{"key":"10.1016\/j.ogc.2023.02.009_bib36","doi-asserted-by":"crossref","first-page":"917304","DOI":"10.1155\/2013\/917304","article-title":"Guideline adherence for intrapartum group B streptococci prophylaxis in penicillin-allergic patients","volume":"2013","author":"Paccione","year":"2013","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.ogc.2023.02.009_bib37","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/AOG.0000000000001297","article-title":"Use of cefazolin for group B streptococci prophylaxis in women reporting a penicillin allergy without anaphylaxis","volume":"127","author":"Briody","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2023.02.009_bib38","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/jama.2018.19283","article-title":"Evaluation and management of penicillin allergy: a review","volume":"321","author":"Shenoy","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.ogc.2023.02.009_bib39","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/AOG.0000000000003662","article-title":"Penicillin allergy in pregnancy: Moving from \u201crash\u201d decisions to accurate diagnosis. Clinical Expert Series","volume":"135","author":"Turrentine","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2023.02.009_bib40","first-page":"259","article-title":"Drug allergy: an updated practice parameter. Joint Task Force on Practice Parameters, American Academy of Allergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology, Joint Council of Allergy, Asthma and Immunology","volume":"105","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.ogc.2023.02.009_bib41","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.anai.2018.07.041","article-title":"Who needs penicillin allergy testing?","volume":"121","author":"Macy","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.ogc.2023.02.009_bib42","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMra993637","article-title":"Cephalosporin allergy","volume":"345","author":"Kelkar","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ogc.2023.02.009_bib43","doi-asserted-by":"crossref","first-page":"428","DOI":"10.12809\/hkmj144327","article-title":"Use of cephalosporins in patients with immediate penicillin hypersensitivity: cross-reactivity revisited","volume":"20","author":"Lee","year":"2014","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.ogc.2023.02.009_bib44","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/INF.0b013e3181c35cc5","article-title":"Macrolide-inducible resistance to clindamycin and the D-est","volume":"28","author":"Woods","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"RR-10","key":"10.1016\/j.ogc.2023.02.009_bib45","first-page":"1","article-title":"Prevention of perinatal group B streptococcal disease: revised guidelines from CDC, 2010. Division of Bacterial Diseases, National Center for Immunization ad Respiratory Diseases, Centers for Disease Control and Prevention (CDC)","volume":"59","author":"Verani","year":"2010","journal-title":"MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"key":"10.1016\/j.ogc.2023.02.009_bib46","doi-asserted-by":"crossref","first-page":"e0128321","DOI":"10.1128\/Spectrum.01283-21","article-title":"Epidemiological Characterization of Group B Streptococcus Infections in Alberta, Canada: An Update from 2014 to 2020","volume":"17","author":"Ma","year":"2021","journal-title":"Microbiol Spectr"},{"issue":"1","key":"10.1016\/j.ogc.2023.02.009_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-021-06186-5","article-title":"Prevalence of group B streptococcus colonization in pregnant women in Jiangsu, East China","volume":"21","author":"Ge","year":"2021","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ogc.2023.02.009_bib48","author":"Clindamycin-Resistant Group"},{"key":"10.1016\/j.ogc.2023.02.009_bib49","first-page":"352","article-title":"Transplacental passage of vancomycin from mother to neonate","volume":"210","author":"Onwuchuruba","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ogc.2023.02.009_bib50","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1080\/14767058.2017.1306049","article-title":"Transplacental passage of vancomycin","volume":"31","author":"Towers","year":"2018","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ogc.2023.02.009_bib51","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2146\/ajhp080434","article-title":"Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists","volume":"66","author":"Rybak","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ogc.2023.02.009_bib52","first-page":"607","article-title":"Comparative evaluation of pharmacist-managed vancomycin dosing in a community hospital following implementation of a system-wide vancomycin dosing guideline","volume":"5","author":"Koliha","year":"2017","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.ogc.2023.02.009_bib53","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Infectious Diseases Society of America. Clin Infect Dis"},{"issue":"suppl 1","key":"10.1016\/j.ogc.2023.02.009_bib54","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1086\/491712","article-title":"The pharmacokinetic and pharmacodynamic properties of vancomycin","volume":"42","author":"Rybak","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ogc.2023.02.009_bib55","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/AOG.0b013e318280d4f6","article-title":"Effectiveness of intrapartum antibiotic prophylaxis for prevention of early-onset group B streptococcal disease","volume":"121","author":"Fairlie","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ogc.2023.02.009_bib56","doi-asserted-by":"crossref","first-page":"525878","DOI":"10.1155\/2013\/525878","article-title":"Duration of intrapartum antibiotics for group B streptococcus on the diagnosis of clinical neonatal sepsis","volume":"2013","author":"Turrentine","year":"2013","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.ogc.2023.02.009_bib57","first-page":"CD000451","article-title":"Membrane sweeping for induction of labour","volume":"2","author":"Boulvain","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ogc.2023.02.009_bib58","doi-asserted-by":"crossref","first-page":"e0145905","DOI":"10.1371\/journal.pone.0145905","article-title":"Antepartum membrane stripping in GBS carriers, is it safe? (the STRIP-G Study)","volume":"10","author":"Kabiri","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ogc.2023.02.009_bib59","first-page":"198","article-title":"Risk factors for early-onset group B streptococcal disease in neonates: a population-based case-control study","volume":"169","author":"Adair","year":"2003","journal-title":"CMAJ (Can Med Assoc J)"}],"container-title":["Obstetrics and Gynecology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854523000438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889854523000438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:27:01Z","timestamp":1760178421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889854523000438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0889854523000438"],"URL":"https:\/\/doi.org\/10.1016\/j.ogc.2023.02.009","relation":{},"ISSN":["0889-8545"],"issn-type":[{"value":"0889-8545","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Group B Streptococcus in Pregnancy","name":"articletitle","label":"Article Title"},{"value":"Obstetrics and Gynecology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogc.2023.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}